estrogen replacement therapy reduces the risk of colorectal cancer

December 1999

There's increasing evidence that estrogen replacement therapy reduces the risk of colorectal cancer.

This benefit started showing up several years ago.

Now it seems that estrogen lowers the risk of colorectal cancer by about a third.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

highlighting the value of pharmacists' interventions
Neurology & Pain Zanaflex (tizanidine), a new drug for muscle spasticity
Neurology & Pain a new drug for advanced Parkinson's disease called Comtan (entacapone, Novartis)
Diabetes many patients with type 1 diabetes don't realize when their blood sugar is too low to drive safely
Vioxx (rofecoxib) for osteoarthritis, acute pain, and primary dysmenorrhea
Migraine whether patients on SSRIs can use one of the "triptans" for migraines
Infectious Diseases new flu drug, Relenza (zanamivir)
Infectious Diseases Do all the new antibacterial soaps, lotions, and gels really help prevent colds and flu
Ophthalmology more people taking lutein for cataracts and macular degeneration
Women's Health estrogen replacement therapy reduces the risk of colorectal cancer
natural products for the cold and flu season
Cardiology low-molecular-weight heparin for unstable angina and non-Q-wave heart attacks
Cardiology amiodarone (Cordarone IV) to help resuscitate cardiac arrest victims
Lots of people are using magnets